This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
 
Sony Wows With Playstation Sales; Futures Higher This Halloween

The futures markets are higher this morning on decent growth data from Europe and a surprise stimulus announcement from the Bank of Japan.

What to Watch on Wall Street for Friday, October 31st 2014

Friday, October 31st is Halloween, but the markets are still open with some big quarterly reports still set to be released.

TASER CEO Rick Smith on Strong Q3 Earnings and Stock Price Surge

TASER CEO, Rick Smith discusses his company's strong Q3 earnings in an exclusive interview with TheStreet's Janet Al-Saad.

Jump in Hiring Lifted LinkedIn's User Engagement, Profit Beat Consensus

Increased hiring made sure users are active on LinkedIn. Together, networking site's subscribers paid $568 million for services in the past three months.

Starbucks Q4 Profit Meets Street Estimates, Top Line Misses

Starbucks posted fourth quarter earnings of $0.74 a share on revenue of $4.2 billion. Wall Street analysts were looking for earnings of $0.74 on sales of $4.23 billion.

Real Money Previews

Jim Cramer on Technology Stocks: Trust Facebook, Here's Why

Yes, Facebook spends a lot. But it's for a purpose.

Jim Cramer on Apple Pay and Drugstores: Apple Is a Win for Walgreen

Adopting Apple's payment system is a smart move.

Herb Greenberg on the Stock Market: Here's Why Twitter Should Sell Itself

Does it really want to explain itself quarter after quarter?

Mad Money Recap

'Mad Money' Lightning Round: Go With UPS, Not YRC Worldwide

Cramer is avoiding Armour Residential, says take the loss on Westport Innovations and think long term about Schlumberger.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

4 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

5 Big Stocks to Trade for Gains as QE3 Ends

Here's how to trade some of the biggest Stocks on Wall Street as the Fed calls for an end to quantitative easing.

4 Stocks Breaking Out on Big Volume

These stocks rising on unusual volume are within range of triggering breakout trades.

5 Stocks Insiders Love Right Now

Insiders at these companies have been scooping up shares of their own stock lately.

5 Stocks Under $10 Making Big Moves Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

MainStreet

Why All-Christmas Shopping Music Won't Be Completely Awful This Holiday Season

All-holiday radio used to be a sure ratings grabber, but Internet radio and short Christmas playlists have forced some stations to get creative.

America's Top 5 'Safe-Haven' Markets for Low-Risk Landlords

Here are ideal markets for the casual investor who has some money to invest in real estate, but little wish for property management hassles.

Why 70% of Potential Homebuyers May Get a Mortgage By Year's End

Helping push the market forward are continued low interest rates, which reduce the cost of buying a home and create more demand from homebuyers.

20 Life Lessons I Learned Chasing Money and Drugs in the Banking and Cannabis Industries

Main Street's whistleblower Brian Penny used to work for Bank of America - now he's exploring the cannabis industry. Here's what he learned.

Fighting Back Against Really High - and Greedy - Resort Fees

Resort fees, often $50 and more per day, are proliferating. Here's how to fight back.

Biotech

Biotech Stock Mailbag: Prosensa, Sarepta, Arena Pharma, Hemispherx

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Aegerion Problems Mount With Poor Quarter and Reduced Guidance

The accusations of cocaine use and having sex with someone else's wife are the least of Marc Beer's problems. Aegerion Pharmaceuticals, the company he runs as CEO, is falling apart.

Aegerion Board Expresses Support for Embattled CEO Amid Drug Use Accusations

Aegerion Pharmaceuticals issued a statement Tuesday night expressing its board's support for CEO Marc Beer in the face of accusations of cocaine use and extramarital sex.

Beyond Wall St.

Deal News

Shutterfly Affirms Independent Course, As Board and Executives Weigh In

Shutterfly plans to go it alone, despite rumors circulating that the photo-sharing site may entertain buyers. That was the word from the company executives during its earnings call.

Here's a Look at the Numbers Behind Boot Barn's Successful IPO

Private equity backer Freeman Spogli could end up generating a 3.7 times return.

Source Says Snow Phipps Wins PE-backed Teasdale Foods for About $200 Million

A source said the New York private equity firm paid about 10 times sales for the provider of Hispanic canned food products.

TheStreetTV
Spin Space

Jim Cramer

Cramer: Fantasy Owners, If Foles Starts Shaky, We May See Sanchez

Jim Cramer offers his best advice to fantasy football owners for week nine of the NFL season.

Herb Greenberg

Herb Greenberg on the Stock Market: Is Coke the New IBM?

I can't remember a time when so many big brands stumbled.

Stephanie Link

Panera Bread Lunches Out Following Earnings but Stephanie Link is a Buyer

Panera Bread is under pressure following earnings, beating on the bottom line, coming in line on the top, guiding down Q4 and not providing guidance for 20145.

Chris Ciaccia

Glu Mobile Gets Unglued Amid Weaker Forecast, Harman International Jumps: Tech Winners & Losers

Glu Mobile cratered Thursday after the mobile games publisher issued a weaker-than-expected forecast. But Harman International Industries soared on earnings strength and demand for...

Adam Feuerstein

Biotech Stock Mailbag: Prosensa, Sarepta, Arena Pharma, Hemispherx

Biotech columnist Adam Feuerstein answers readers' questions about health care.

Dan Freed

Hedge Fund Billionaires Support New York Attorney General Schneiderman

Chanos, Einhorn, Soros and Paulson are some of the prominent hedge fund names who are backing Schneiderman's 2014 reelection campaign.

Ted Reed

Alaska Airlines Is Downgraded Because of Delta's Seattle Incursion

Alaska Airlines shares have gained 44% this year, mid-range for airline stocks, and a leading airline analyst says Delta's Seattle buildup is bound to hurt the stock.

Leon Lazaroff

Tim Cook’s Gay Declaration Needs a Lot More CEO Support

Tim Cook's declaration may encourage other CEOs and employees to come out as gay in the workplace, but it's easier to be out if you run a company like Apple.

Submit an article to us!
DOW 17,195.42 +221.11 1.30%
S&P 500 0.00 -2.75 -0.14%
NASDAQ 4,566.1380 +16.9120 0.37%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs